关于我们
关于我们
我武生物集团
wolwo GROUP
2002年
year established
成立时间
2012年
Rate First
市场占有率第一
2014年
Company Listing
公司上市
作为亚洲最大的脱敏药物研发、生产企业,我武将继续秉承“治病救人、实业报国”的企业宗旨,以高度的社会责任感和完备的质量监管体系,生产“改善人类的生存质量、延长人类的健康寿命”的医药产品,为建设成为“国际医药行业的标志企业”而全力以赴,并同时使公司的股东和员工获得长足的发展和收益。
Caring for human health and improving the life quality
We are committed to changing the backward status of China's pharmaceutical industry. As a member of China's pharmaceutical companies, we hope to make our due contributions to the health and wellbeing of people worldwide.
The core product of Wolwo - "Dermatophagoides Farinae Drops" has helped tens of thousands of patients heal or allergic symptoms alleviated, relieve pain and greatly improve patients’ quality of life.
Wolwo is actively carrying out stem cell research, aiming to develop and apply advanced stem cell technology to treat aging-related degenerative diseases and immune disorders-related diseases.
Pharmaceutical industry is a very special, so is medicine a very special kind of commodity as a tool to maintain life. As a pharmaceutical company, Wolwo is engaged in a business of accumulating good deeds. Treating diseases and saving people is our ultimate mission.
公众号
学术公众号
Copyright © 2018 浙江我武生物科技股份有限公司 All Rights Reserved 浙ICP备15038433号 浙公网安备 33052102000247号